Lifeist Wellness Inc. (NXTTF)
| Previous close | 0.0845 |
| Open | 0.0706 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.0700 - 0.0900 |
| 52-week range | 0.0500 - 0.3510 |
| Volume | |
| Avg. volume | 429,786 |
| Market cap | 30.705M |
| Beta (5Y monthly) | 1.50 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0550 |
| Earnings date | 28 Mar 2022 - 01 Apr 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Lifeist’s Consumer-focused Roilty Brand Wins Coveted “Canadian LP Brand of Year” Award at ADCANN
Continued Progress for Lifeist’s Cannabis Business in 2021 Roilty: 2021 Canadian LP Brand of the Year Lifeist’s Consumer-focused Roilty Brand Wins Coveted “Canadian LP Brand of Year” Award at ADCANN TORONTO, Jan. 14, 2022 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a health-tech company that leverages advancements in science and technology to enable you to find your path to wellness, today announced that its Cannabis 2.0
- GlobeNewswire
Lifeist Wellness Inc. Issues Long Term Incentives
TORONTO, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a health-tech company that leverages advancements in science and technology to enable you to find your path to wellness, today announced issuance of long-term incentives in favour of directors, officers and a former director of the Company. The board of directors of the Company (“Board”) recognises that long term incentives, vesting over multiple years, st
- GlobeNewswire
Lifeist Subsidiary Mikra Cellular Sciences to Launch First Product “CELLF” to Combat Brain Fog and Unlock Healthy Aging, Announces U.S. Patent Application and Pre-Clinical Study
CELLF Single-serve Sachet (Image of CELLF single-serve sachet by Mikra Cellular Sciences) CELLF Product Package (Image of CELLF product package by Mikra Cellular Sciences) CELLF Product & Community Launch (Image of CELLF mobile marketing by Mikra Cellular Sciences) - Mikra patent focusing on novel cellular therapeutic targeting systemic fatigue- Mikra partners with InVivo Biosystems for pre-clinical trials to strengthen patent application and generate further data confirming expression pathways
